Ophthalmology
Eyes & vision clinical trials
Eye disease and conditions that affect sight. We’re tracking 1,764 recruiting studies in this area right now.
By phase
- Not applicable1,204
- Phase 3133
- Phase 2119
- Phase 1117
- Phase 492
- Phase 1/Phase 285
- Phase 2/Phase 314
Top conditions
- Glaucoma107
- Myopia88
- Cataract76
- Diabetic Retinopathy51
- Dry Eye38
- Keratoconus34
- Retinitis Pigmentosa33
- Age-Related Macular Degeneration31
- Amblyopia26
- Eye Diseases24
- Graves Disease24
- Sjogren's Syndrome24
- Dry Eye Disease (DED)23
- Multiple Sclerosis22
- Astigmatism21
- Ocular Hypertension21
- Diabetic Macular Edema20
- Macular Degeneration20
Leading sponsors
- Zhongshan Ophthalmic Center, Sun Yat-sen University25
- Medical University of Vienna20
- Second Affiliated Hospital, Zhejiang University, School of Medicine19
- Fondation Ophtalmologique Adolphe de Rothschild18
- Assistance Publique - Hôpitaux de Paris16
- National Taiwan University Hospital16
- The Hong Kong Polytechnic University16
- Eye & ENT Hospital of Fudan University15
- National Eye Institute (NEI)15
- Shanghai Eye Disease Prevention and Treatment Center15
Where studies are running
- California133
- Arizona68
- Florida43
- Maryland39
- Texas37
- New York36
- Massachusetts35
- Alabama26
- North Carolina20
- Pennsylvania20
Recruiting studies1,764 total
- NCT07777861RecruitingPhase 2
Testing an eye drop for worsening glaucoma
This study tests an eye drop (G01) for people with primary open-angle glaucoma that is getting worse despite current treatments. It aims to see if G01 can safely slow down or stop the progression of glaucoma.
Beijing, Beijing MunicipalityAges 18–80 - NCT07782619Recruiting
Comparing two eye measurement devices in different eye conditions
This study compares two eye measurement devices to see if they give similar results in people with healthy eyes, keratoconus (a cone-shaped cornea), daily contact lens use, dry eye, or after laser eye surgery. Participating may help ensure these devices are accurate for different patients.
Salt Lake City, UtahAges 21 years+ - NCT07776210RecruitingPhase 3
Eye drops for chronic dry eye after stem cell transplant
This trial tests an eye drop solution for people with chronic dry eye caused by graft-versus-host disease after a stem cell transplant. It aims to see if the drops can reduce eye discomfort and improve the eye surface.
Beverly Hills, CaliforniaAges 18 years+ - NCT07776522RecruitingPhase 2
Gene therapy for wet age-related macular degeneration
This trial tests a one-time gene therapy injection under the retina for people with wet age-related macular degeneration (AMD), which causes blurry vision from abnormal blood vessels. It aims to reduce the need for frequent eye injections by delivering a treatment that may help the eye produce its own medicine.
Beijing, Beijing MunicipalityAges 50–85 - NCT07780890Recruiting
Measuring eye hydration with light
This study uses a non-invasive imaging technique called Brillouin hydration mapping to measure hydration levels in different parts of the eye. It aims to help doctors better understand how hydration affects eye health and disease.
Boston, MassachusettsAges 20–79 - NCT07775872Recruiting
Study of polg-related disease over time
This study follows people of all ages with a confirmed POLG-related disease to learn how the condition changes over time. The information collected may help design better care and future treatments.
San Diego, CaliforniaAges Any age - NCT07777978Recruiting
Home exercise and education for chronic venous insufficiency
This study tests a structured home-based exercise and education program for people with chronic venous insufficiency – a condition where veins in the legs have trouble sending blood back to the heart. If you qualify, you would do the program for 12 weeks to see if it helps improve your symptoms.
Bolu, BoluAges 18 years+ - NCT07780916Recruiting
Long-term results of trabectome surgery for glaucoma
This study looks at the long-term results of a specific glaucoma surgery (trabectome) done at one hospital. If you had this surgery there between 2019 and 2021, researchers want to check your eye health now to see how well it worked.
Würzburg, BavariaAges 18 years+ - NCT07778797Recruiting
New lens for children after cataract surgery
This study tests a new lens for children who have had both cataracts removed and artificial lenses implanted. It may help improve vision after their surgery.
Shanghai, Shanghai MunicipalityAges 4–12 - NCT00286637Recruiting
New tests to diagnose glaucoma and related eye problems
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05845723RecruitingPhase 2
Study drugs for blood-vessel Behçet’s to reduce inflammation
This Phase 2 trial tests tocilizumab and tofacitinib to see if they can better control vascular (blood-vessel) Behçet’s syndrome. It may help by lowering inflammation and reducing complications from aneurysms in the aorta or peripheral arteries.
Beijing, Beijing MunicipalityAges 18–65 - NCT04416724Recruiting
Surgery versus laser for early pseudoexfoliation glaucoma
This trial compares cataract surgery (phacoemulsification) versus a laser treatment (SLT) as the first treatment for pseudoexfoliation glaucoma. It aims to find which approach lowers eye pressure and helps prevent progression for people with early disease and cataracts.
Halifax, Nova ScotiaAges 50 years+ - NCT07774637Recruiting
Surgery outcomes for myopic foveoschisis
This study is looking at how well people do after eye surgery for a condition called myopic foveoschisis, which causes a part of the retina to swell. The study will check if your vision improves after surgery and look for signs of complications.
Singapore, SingaporeAges 40–90 - NCT07771998Recruiting
Skin and eye tolerance test for sensitive skin
This study tests a product on women with sensitive skin to see if it causes any skin or eye irritation. It helps find out if the product is safe and gentle for daily use.
Osasco, São PauloAges 18–60 - NCT07770685RecruitingPhase 1/Phase 2
Study of a new eye drop for advanced glaucoma
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
Boston, MassachusettsAges 18 years+ - NCT07770828RecruitingPhase 3
Gene therapy for advanced dry age-related macular degeneration
This trial tests an experimental gene therapy, OCU410, for people with geographic atrophy, an advanced form of dry AMD that causes blind spots in the center of vision. The study aims to see if this treatment can slow down the progression of the disease and help preserve remaining vision.
Phoenix, ArizonaAges 55 years+ - NCT07768735Recruiting
Camera study for checking the clear front part of the eye
This study tests a special camera (called UNITY DX) that takes detailed pictures of the cornea, the clear front part of your eye. It aims to see if this camera can help doctors spot problems in the cornea earlier or more accurately.
Salt Lake City, UtahAges 22 years+ - NCT07771699Recruiting
Brain stimulation for balance and thinking in older adults with glaucoma
This study tests a non-invasive brain stimulation technique to see if it can improve balance and thinking in older adults with glaucoma. It involves a series of sessions where a mild electrical current is applied to the brain.
Kowloon, Hong KongAges 55 years+ - NCT07774975RecruitingPhase 1
Safety study of pitavastatin nanoparticles for retinitis pigmentosa
This trial tests a new form of the drug pitavastatin, which is usually used for cholesterol, but here it's given as tiny particles injected into the eye. The goal is to see if it's safe and might help people with retinitis pigmentosa, a condition that causes vision loss.
FukuokaAges 18–70 - NCT07769944Recruiting
Measuring lens position after cataract surgery
This study uses a special ultrasound to check how well the new artificial lens stays centered after cataract surgery. It may help doctors improve surgery outcomes for clearer vision.
Sohag, Sohag GovernorateAges Up to 45 years - NCT02182921Recruiting
Cataract surgery outcomes study
This study looks at how cataract surgery affects patients’ vision and recovery. You may be invited if you have cataracts and can participate in eye exams, and if mental health or thinking issues won’t interfere with the study.
Shanghai, Shanghai MunicipalityAges Up to 90 years - NCT07764198Recruiting
Gabor visual training for adult lazy eye
This study tests a home-based visual training program that uses special patterns to help improve vision in adults with amblyopia, often called lazy eye. It may offer a new way to gain visual improvement.
ShanghaiAges 18–39 - NCT07762872Recruiting
Satralizumab during early NMOSD attacks
This study looks at how well the medication satralizumab works when started early during an NMOSD attack, along with standard treatments. The aim is to see if adding this drug can help reduce the impact of the attack and improve outcomes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07758569Recruiting
AI tool for detecting glaucoma in eye photos
This study is testing an artificial intelligence tool that can automatically detect signs of glaucoma in photos of the retina. It may help confirm that the AI can accurately identify glaucoma, which could lead to faster diagnosis and monitoring for patients.
AlexandroupoliAges 18 years+
Common questions
- How many eyes & vision clinical trials are recruiting?
- Clin2 is tracking 1,764 recruiting ophthalmology studies from the U.S. registry right now, out of 2,747 we cover in this area in total.
- What does “Eyes & vision” cover here?
- Eye disease and conditions that affect sight. We group each study into eyes & vision based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a eyes & vision trial near me?
- Use the search to filter eyes & vision studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.